Article | August 24, 2016

Solutions to Today's Biomanufacturing Challenges

Source: Patheon, part of Thermo Fisher Scientific

by John Ward, Vice President of Engineering at Patheon, part of Thermo Fisher Scientific

complex large molecules

by John Ward, Vice President, Engineering, Patheon

Biopharmaceutical companies take on a lot of risk developing new large molecule drugs. With more complex molecules in development, changing capacity needs, uncertain forecasts and increased competition, the market demands flexibility and innovative approaches to address today’s new challenges.

Patheon, part of Thermo Fisher Scientific